Mirum Pharmaceuticals Inc (MIRM) — Capital Reinvestment Ratio
Latest as of December 2025:
0.10x
Mirum Pharmaceuticals Inc (MIRM) has a Capital Reinvestment Ratio of 0.10x as of December 2025, meaning it reinvests 0% of its operating cash flow ($6.07 Million) in capital expenditures ($600.00K). See Mirum Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
$6.07 Million
USD
Capital Expenditures
$600.00K
USD
Data as of
Dec 2025
Most recent filing
Mirum Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Mirum Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Mirum Pharmaceuticals Inc from 2024 to 2025. For live market cap and broader valuation context, see MIRM stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $55.83 Million | $954.00K | ▼ -82.2% |
| 2024 | 0.10x | $10.32 Million | $993.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow